Virios Therapeutics, Inc.·4

May 24, 10:24 AM ET

Duncan Gregory Scott 4

4 · Virios Therapeutics, Inc. · Filed May 24, 2022

Insider Transaction Report

Form 4
Period: 2022-05-23
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Purchase

    Common Stock

    2022-05-23$4.52/sh+7,500$33,90032,461 total

Documents

1 file
  • 4
    form4-05242022_070548.xmlPrimary